Professional Experience
- Head of the Thoracic Tumors and Head & Neck Cancer Unit at Vall d’Hebron University Hospital
- Clinical oncologist at Hospital Quirón Barcelona
- Codirector of the Clinical Research Program at Vall d’Hebron Institute of Oncology (VHIO)
- Long-standing leadership in early-phase clinical trials and molecular oncology
Academic Contributions
- Professor of Medicine at the Autonomous University of Barcelona
- Regular lecturer at international congresses and oncology symposia
- Mentor and educator in thoracic oncology and molecular diagnostics
- Editor and reviewer for journals such as Annals of Oncology and Journal of Thoracic Oncology
Areas of Expertise
- Non-small cell lung cancer (NSCLC) – including personalized treatment with molecular testing
- Small cell lung cancer (SCLC) – advanced approaches including immunotherapy
- Head and neck tumors – integrating surgery, chemo- and radiotherapy
- Use of circulating tumor DNA (ctDNA) and liquid biopsy to monitor treatment progress
Publications and Research
Dr. Enriqueta Felip is the author of over 400 scientific publications in peer-reviewed medical journals. Her research focuses on innovative treatments in lung cancer, including immunotherapy and molecular-targeted drugs.
Selected publications:
- IMpower010 trial: Study on adjuvant atezolizumab in early-stage NSCLC
- Tarlatamab clinical trial: Evaluating novel treatments for relapsed small cell lung cancer
- ctDNA monitoring: Investigating the role of circulating tumor DNA in lung cancer management
Her academic profile is available on platforms such as PubMed, ORCID, and ResearchGate.
Patient Care Philosophy
- Believes in transparent, empathetic communication with patients
- Focuses on personalized treatment plans tailored to genetic and molecular profiles
- Advocates for international access to care through virtual consultations
- Known for creating strong doctor-patient relationships based on trust and collaboration
Professional Affiliations
- President of the Spanish Society of Medical Oncology (SEOM), former Vice-President
- Board member of the International Association for the Study of Lung Cancer (IASLC)
- Member of European Society for Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO)
- Active contributor to international guidelines and scientific boards
- Recipient of the ESMO Women for Oncology Award and other distinguished honors
FAQs
- Is Dr. Enriqueta Felip board-certified?
- Yes, she is board-certified in Medical Oncology in Spain and internationally recognized in her field.
- What types of cancers does she treat?
- She specializes in thoracic oncology, including lung cancer (NSCLC, SCLC), mesothelioma, and head and neck tumors.
- Does she treat international patients?
- Yes, she offers care to international patients and provides online consultations as part of Hospital Quirón Barcelona’s services.
- How long is the typical hospital stay for treatment?
- It varies by procedure, but the hospital offers both outpatient and inpatient treatment plans based on the patient’s condition.
- What languages does she speak?
- Dr. Felip speaks Spanish and English. Multilingual support is also available through the hospital.
- Is she involved in research or clinical trials?
- Yes, she leads numerous clinical trials and translational research programs in lung cancer and precision oncology.
- Can she provide a second opinion remotely?
- Yes, she is available for remote consultations and second opinions for patients worldwide.
